Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.

Nature | 2012

Stressors motivate an array of adaptive responses ranging from 'fight or flight' to an internal urgency signal facilitating long-term goals. However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments. Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal. An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry. Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors and other arousing environmental stimuli, acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF's capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.

Pubmed ID: 22992525 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: F31-MH086269
  • Agency: NIDA NIH HHS, United States
    Id: F32-DA026273
  • Agency: NIDA NIH HHS, United States
    Id: R01-DA030074
  • Agency: NIDA NIH HHS, United States
    Id: F32 DA026273
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA016782
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH079292
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA030074
  • Agency: NIMH NIH HHS, United States
    Id: R01-MH079292
  • Agency: NIMH NIH HHS, United States
    Id: F31 MH086269
  • Agency: NIDA NIH HHS, United States
    Id: R01-DA009082
  • Agency: NIDA NIH HHS, United States
    Id: R01-DA016782
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA009082
  • Agency: NIDA NIH HHS, United States
    Id: K05 DA020570

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Novus Biologicals (tool)

RRID:SCR_004286

Commercial antibody vendor which supplies antibodies and other products to life science researchers.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions